Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Tolerability of 50 ug of ChulaCov19-BNA159 mRNA Vaccine in Poland
Total 0 results
Nothing found
Sponsors and Collaborators
Harvard-NIOSH Education and Research Center (ERC)
M.p. van den Berg, MD, PhD, professor in Cardiology
See You At The Summit
Metabolic Research Unit
Tweddle Child and Family Health Service
Dr. Melody Smith, MD, MS
Zhejiang Rehabilitation Center
Canadian Cystic Fibrosis Foundation
Medical Information Technology (MedIT), RWTH Aachen University
Colegio Oficial de Enfermeras y Enfermeros de Barcelona
Athersys, Inc
Sociedad Española de Cirugía Torácica
Unitat d'Hemostasia i Trombosi. Hospital de la Santa Creu i Sant Pau
KAI Pharmaceuticals
Magdalena Salcedo
Kansas City Bioanalytical Laboratories
Tianjin Chasesun Pharmaceutical Co., LTD
CrashCourse AB
MMJ Labs LLC
Miami Cardiac and Vascular Institute
View Full List
Medical Conditions
Anaplastic Lymphoma Kinase Gene Mutation
Older People With Cardiovascular Disease Risk
Oropharyngeal Basaloid Carcinoma
Combretastatin A4 Phosphate
Thoraric Surgery
Skin Androgenization
Stage III Melanoma
Neoplasia; Intraepithelial, Cervix
Peripheral Microvascular Symptoms
Ductal Carcinomas
Malignant Tumor
Single Traumatic Limb Injury With Severe Pain (Score > 5/10 on Numerical Pain Scale)
Advanced Thymic Epithelial Tumor
Hepatitis A Virus Infection
Discrete Choice Experiment
Pesticide-Induced Parkinsonism
Stage II Ovary Cancer
Ingrown Toenail
Peripheral Primitive Neuroectodermal Tumor of Bone
Unresectable Stage III or IV Malignant Melanoma
View Full List
Drug Interventions
TV-46046 - 300 mg/mL (if warranted)
Cabotegravir, Rilpivirine Drug Combination
IPX203 280 mg
HB0030 injection
Usual care
CSII,ALA,MET,RSG
0/0mg taken first
Marijuana
Thrombolytic Therapy
LC Bead loaded with doxorubicin
Triamcinolone
Botox
Paracetamol
Binimetinib Pill
Ruxolitinib
Simvastatin 10mg
Toripalimab
Group A propofol + remifentanil
Chloroquine (CQ) prophylaxis
9-aminocamptothecin
View Full List
CROs by country
Contract Research Organizations in Belarus
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Congo
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Guinea
Contract Research Organizations in Moldova
Contract Research Organizations in Oman
Contract Research Organizations in Papua New Guinea
Contract Research Organizations in Philippines
Contract Research Organizations in Russia
Contract Research Organizations in Saudi Arabia
Contract Research Organizations in Uganda
Contract Research Organizations in Zimbabwe
CRO list by country
CROs in Nigeria
Bispharm Clinical
54gene’s Clinical Programs Group (CPG)
ACROSS Global
Celero
SGS
All CROs in Nigeria
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe